CHD(CHD)
CHD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $6.22B | $6.48B | $6.72B | $6.97B | $7.25B |
| Low | $6.16B | $6.38B | $6.66B | $6.91B | $7.19B |
| High | $6.29B | $6.61B | $6.82B | $7.05B | $7.34B |
| EBITDA Avg | $1.26B | $1.32B | $1.37B | $1.42B | $1.47B |
| Low | $1.25B | $1.30B | $1.35B | $1.40B | $1.46B |
| High | $1.28B | $1.34B | $1.39B | $1.43B | $1.49B |
| EBIT Avg | $1.02B | $1.06B | $1.10B | $1.14B | $1.18B |
| Low | $1.01B | $1.04B | $1.09B | $1.13B | $1.17B |
| High | $1.03B | $1.08B | $1.11B | $1.15B | $1.20B |
| Net Income Avg | $914M | $997M | $1.07B | $1.13B | $1.17B |
| Low | $897M | $959M | $1.02B | $1.12B | $1.15B |
| High | $931M | $1.04B | $1.11B | $1.15B | $1.19B |
| EPS Avg | $3.77 | $4.05 | $4.34 | $4.65 | $4.78 |
| Low | $3.67 | $3.93 | $4.17 | $4.59 | $4.72 |
| High | $3.81 | $4.24 | $4.55 | $4.72 | $4.85 |
| Analysts (Rev / EPS) | 10 / 10 | 11 / 11 | 7 / 4 | 3 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.58B | $1.66B | $1.54B | $1.59B | $1.64B | $1.72B | $1.61B | $1.66B |
| Low | $1.56B | $1.63B | $1.52B | $1.57B | $1.62B | $1.70B | $1.59B | $1.64B |
| High | $1.61B | $1.71B | $1.57B | $1.63B | $1.68B | $1.76B | $1.64B | $1.69B |
| EBITDA Avg | $321M | $337M | $314M | $324M | $334M | $350M | $327M | $337M |
| Low | $316M | $331M | $310M | $320M | $330M | $345M | $323M | $333M |
| High | $327M | $347M | $320M | $331M | $341M | $357M | $334M | $344M |
| EBIT Avg | $257M | $270M | $252M | $260M | $268M | $281M | $263M | $271M |
| Low | $254M | $265M | $249M | $257M | $265M | $277M | $259M | $267M |
| High | $262M | $279M | $257M | $265M | $274M | $287M | $268M | $276M |
| Net Income Avg | $216M | $244M | $238M | $231M | $234M | $262M | $253M | $251M |
| Low | $209M | $232M | $234M | $227M | $230M | $257M | $249M | $246M |
| High | $223M | $259M | $244M | $237M | $240M | $269M | $260M | $257M |
| EPS Avg | $0.91 | $1.02 | $1.00 | $0.97 | $0.98 | $1.10 | $1.06 | $1.05 |
| Low | $0.88 | $0.97 | $0.98 | $0.95 | $0.96 | $1.08 | $1.04 | $1.03 |
| High | $0.93 | $1.09 | $1.03 | $1.00 | $1.01 | $1.13 | $1.09 | $1.08 |
| Analysts (Rev / EPS) | 9 / 12 | 9 / 11 | 7 / 4 | 4 / 4 | 4 / 7 | 7 / 4 | 7 / 5 | 3 / 6 |